CBT 125

Drug Profile

CBT 125

Alternative Names: CBT-125

Latest Information Update: 29 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cipla BioTec
  • Class Peptide hormones
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Diabetes insipidus; Diabetes mellitus

Most Recent Events

  • 29 Aug 2016 Discontinued - Registered for Diabetes insipidus in India (unspecified route)
  • 29 Aug 2016 Discontinued - Registered for Diabetes mellitus in India (unspecified route)
  • 30 Apr 2016 Registered for Diabetes insipidus in India (unspecified route) before April 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top